Newsletter
Language
Language:
 
News
Archival Issues
Volume 18, 2016
Volume 17, 2015
Volume 16, 2014
Volume 15, 2013
Volume 14, 2012
Volume 13, 2011
Volume 12, 2010
Volume 11, 2009
Volume 10, 2008
Volume 9, 2007
Volume 8, 2006
Volume 7, 2005
Volume 6, 2004
Volume 5, 2003
Volume 4, 2002
Volume 3, 2001
Volume 2, 2000
Volume 1, 1999
Search
 » 
Journal Abstract
 
Effect of Single Preoperative Dose of Tranexamic Acid on Blood Loss and Transfusion in Hip Arthroplasty
Marcin Jaszczyk, Dariusz Kozerawski, Łukasz Kołodziej, Arkadiusz Kazimierczak, Patryk Sarnecki, Łukasz Sieczka
Ortop Traumatol Rehabil 2015; 17(3):265-273
ICID: 1162426
Article type: Original article
IC™ Value: 3.00
Abstract provided by Publisher
 
Background. The aim of the study was to assess the effect of a single intravenous dose of tranexamic acid administered before surgery in patients undergoing total cementless hip arthroplasty on: intra-, post-, and perioperative blood lost, the number of patients requiring transfusion, the incidence of thromboembolic complications
Material and methods. The study enrolled 124 patients, who were randomly divided into two groups. The experimental group (61 patients) received an intravenous dose of 15 mg/kg of tranexamic acid 20 minutes before the skin incision, while the control group (63 patients) did not receive this drug. We analysed intraoperative blood loss (volume of blood in the aspirator), postoperative blood loss (volume of blood drained), total perioperative blood loss, and the number of patients requiring transfusion as well as the number of thromboembolic complications in both groups.
Results. In the experimental group, mean intraoperative blood loss was significantly lower at 216 ml compared to 408.5 ml in the control group (p=0.00421). Postoperative blood loss on the first postoperative day was also lower in the experimental group (246.3 ml) as compared with the control group (358 ml, p=0.000097). Estimated perioperative blood loss in the experimental group was lower as well, reaching 779 ml, vs. 1315.5 ml in the control group (p=0.00567). The percentage of patients requiring transfusion in the experimental group (3.27%) was significantly lower than in the control group (22.22%) (p=0.00166). The use of tranexamic acid did not influence the number of thromboembolic complications (p=0.3075).
Conclusions. 1. The administration of 15 mg/kg of tranexamic acid 20 minutes before surgery decreases the need for postoperative transfusion of allogeneic blood due to a significant reduction in intra-, post-, and perioperative blood loss. 2. Seeing that this method does not increase the number of thromboembolic complications and is simple and inexpensive, it should be considered worthy of recommendation in total cementless hip arthroplasty.

ICID 1162426

DOI 10.5604/15093492.1162426
PMID 26248628 - click here to show this article in PubMed
 
FULL TEXT 590 KB


Related articles
  • in IndexCopernicus™
         transfuzja krwi [0 related records]
         aloplastyka stawu biodrowego [0 related records]
         kwas traneksamowy [0 related records]
         thromboembolic complications [2 related records]
         blood loss [3 related records]
         Blood Transfusion [363 related records]
         hip arthroplasty [5 related records]
         Tranexamic Acid [2 related records]

  • Related articlesin PubMed database
  • in PubMed database [ related records]


  •  

    Copyright © Ortopedia Traumatologia Rehabilitacja  2017
    Page created by Index Copernicus Ltd. All Rights reserved.